Author:
Bottens Ryan A.,Yamada Tohru
Abstract
Cell-Penetrating Peptides (CPPs) are short peptides consisting of <30 amino acids. Their ability to translocate through the cell membrane while carrying large cargo biomolecules has been the topic of pre-clinical and clinical trials. The ability to deliver cargo complexes through membranes yields potential for therapeutics and diagnostics for diseases such as cancer. Upon cellular entry, some CPPs have the ability to target specific organelles. CPP-based intracellular targeting strategies hold tremendous potential as they can improve efficacy and reduce toxicities and side effects. Further, recent clinical trials show a significant potential for future CPP-based cancer treatment. In this review, we summarize recent advances in CPPs based on systematic searches in PubMed, Embase, Web of Science, and Scopus databases until 30 September 2022. We highlight targeted delivery and explore the potential uses for CPPs as diagnostics, drug delivery, and intrinsic anti-cancer agents.
Funder
NIH
Michael Reese Pioneer in Research Award
Reference166 articles.
1. Twenty years of cell-penetrating peptides: From molecular mechanisms to therapeutics;Heitz;Br. J. Pharmacol.,2009
2. Amalia, S., Azhar, R., and Ghulam, H. Cell-Penetrating Peptides: A Challenge for Drug Delivery. Cheminformatics and Its Applications, 2020.
3. Cell-penetrating peptides: Possibilities and challenges for drug delivery in vitro and in vivo;Skotland;Molecules,2015
4. Efficient intracellular delivery of proteins by a multifunctional chimaeric peptide in vitro and in vivo;Yu;Nat. Commun.,2021
5. Cell penetrating peptides: A concise review with emphasis on biomedical applications;Derakhshankhah;Biomed. Pharmacother.,2018
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献